Skip to main content
. 2017 Mar 6;12(3):e0172884. doi: 10.1371/journal.pone.0172884

Fig 3. IGCs are associated with poor clinical outcomes.

Fig 3

Expression levels of IGCs were identified from 525 TCGA bulk GBM microarray expression samples. Samples for which expression levels were highest and lowest (top and bottom 10%) were then compared for time to death. Median days to death for each group reported on graph.